Advertisement


Flora E. van Leeuwen, PhD, on Hodgkin Lymphoma Treatment: Toxicities in Female Survivors

2018 Cancer Survivorship Symposium: Advancing Care and Research

Advertisement

Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).



Related Videos

Survivorship

Carrie R. Howell, PhD, on Reducing Risks for Childhood Cancer Survivors: Trial Results

Carrie R. Howell, PhD, of St. Jude Children’s Research Hospital, discusses study findings on a web-based exercise intervention for adolescent survivors, who are at increased risk f...

Survivorship

Lynda M. Beaupin, MD, on Adhering to Follow-up Care: An Analysis

Lynda M. Beaupin, MD, of the Roswell Park Cancer Institute, discusses her findings on the factors contributing to adolescent and young adult cancer survivors not seeking follow-up ...

Survivorship

Patricia A. Ganz, MD, on Progress in Cancer Survivorship Care

Patricia A. Ganz, MD, of the University of California, Los Angeles, and this year’s recipient of the Ellen Stovall Award for Advancement of Cancer Survivorship Care, discusses her ...

Survivorship

Lawrence N. Shulman, MD, on The New Survivorship Standard: Expert Perspective

Lawrence N. Shulman, MD, of Abramson Cancer Center at the University of Pennsylvania, discusses the Commission on Cancer’s efforts to promote robust survivorship care and how its n...

Survivorship

Genevieve Chaput, MD, on Teaching Primary Care Providers About Survivorship

Genevieve Chaput, MD, of McGill University Health Centre, discusses an accredited workshop that increased primary care providers’ confidence and knowledge about cancer survivorship...

Advertisement

Advertisement



;
Advertisement